Max Hentges
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Max Hentges has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Béla-Simon Paschold
Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Anaesthesiology and Intensive Care Medicine, Faculty of Medicine, University of Ulm, Ulm, Germany
2 shared publications Guanqing Chen
2 shared publications- Luca J. Wachtendorf
Harvard Medical School Boston MA USA
2 shared publications - Maximilian Sebastian Schaefer
Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Massachusetts; Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Anesthesiology, Medical Faculty and University Hospital Duesseldorf, Duesseldorf, Germany
2 shared publications - Simone Redaelli
Department of Anesthesia, Critical Care and Pain Medicine, Center for Anesthesia Research Excellence (CARE), Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USA
2 shared publications - Theresa Tenge
Medical Faculty and University Hospital Düsseldorf, Heinrich‐Heine‐University Düsseldorf
2 shared publications
Latest Publications
- 6 July 2025
- Published by Wiley in Anaesthesia
Dose‐dependent relationship between intra‐operative ketamine administration and postoperative delirium: a retrospective cohort study
Summary: Introduction: Ketamine is used frequently as an adjunct for general anaesthesia, exerting analgesic and opioid‐sparing properties at lower doses and psychotomimetic effects at higher doses. All dose ranges may have effects on the incidence of postoperative delirium, but clinical trials have been equivocal. We hypothesised that intra‐operative low‐dose ketamine is associated with a lower risk of postoperative delirium.Methods: A total of 106,982 adult patients undergoing general anaesthesia for non‐cardiac, non‐neurosurgical and non‐transplant procedures between 2008 and 2024 were included. Primary exposure was the intra‐operative cumulative ketamine dose (mg.kg‐1 body weight) dichotomised into high vs. low‐dose, based on the median of the cohort. Primary outcome was postoperative delirium within 7 days, based on keyword‐based search strategy, manual chart review, Confusion Assessment Method recordings and International Classification of Diseases diagnostic codes. Multivariable logistic regression and fractional polynomial regression analyses to assess a potential nonlinear dose–response relationship were performed.Results: Postoperative delirium occurred in 2837 (2.7%) patients. In total, 12,199 (11.4%) patients received ketamine, with a median (IQR [range]) intra‐operative dose of 0.35 (0.25–0.52 [0.01–3.86]) mg.kg‐1. Compared with patients not receiving ketamine, a low dose (≤ 0.35 mg.kg‐1, 6109 patients) was associated with lower risks of postoperative delirium (adjusted odds ratio 0.74 (95%CI 0.59–0.89), adjusted risk difference ‐0.7% (95%CI ‐1.0 to ‐0.3%); p = 0.003). Higher doses of ketamine (> 0.35 mg.kg‐1, 6090 patients) did not affect the risk of postoperative delirium (adjusted odds ratio 1.00 (95%CI 0.85–1.18); p = 0.96). Fractional polynomial regression analyses indicated a U‐shaped dose–response relationship, with a minimum postoperative delirium risk at a cumulative ketamine dose of 0.25–0.34 mg.kg‐1.Discussion: Intra‐operative low‐dose ketamine was associated with a lower risk of postoperative delirium, while high doses did not influence the risk.
- 6 July 2025
- Published by Wiley in Anaesthesia
Dose‐dependent relationship between intra‐operative ketamine administration and postoperative delirium: a retrospective cohort study
Summary: Introduction: Ketamine is used frequently as an adjunct for general anaesthesia, exerting analgesic and opioid‐sparing properties at lower doses and psychotomimetic effects at higher doses. All dose ranges may have effects on the incidence of postoperative delirium, but clinical trials have been equivocal. We hypothesised that intra‐operative low‐dose ketamine is associated with a lower risk of postoperative delirium.Methods: A total of 106,982 adult patients undergoing general anaesthesia for non‐cardiac, non‐neurosurgical and non‐transplant procedures between 2008 and 2024 were included. Primary exposure was the intra‐operative cumulative ketamine dose (mg.kg‐1 body weight) dichotomised into high vs. low‐dose, based on the median of the cohort. Primary outcome was postoperative delirium within 7 days, based on keyword‐based search strategy, manual chart review, Confusion Assessment Method recordings and International Classification of Diseases diagnostic codes. Multivariable logistic regression and fractional polynomial regression analyses to assess a potential nonlinear dose–response relationship were performed.Results: Postoperative delirium occurred in 2837 (2.7%) patients. In total, 12,199 (11.4%) patients received ketamine, with a median (IQR [range]) intra‐operative dose of 0.35 (0.25–0.52 [0.01–3.86]) mg.kg‐1. Compared with patients not receiving ketamine, a low dose (≤ 0.35 mg.kg‐1, 6109 patients) was associated with lower risks of postoperative delirium (adjusted odds ratio 0.74 (95%CI 0.59–0.89), adjusted risk difference ‐0.7% (95%CI ‐1.0 to ‐0.3%); p = 0.003). Higher doses of ketamine (> 0.35 mg.kg‐1, 6090 patients) did not affect the risk of postoperative delirium (adjusted odds ratio 1.00 (95%CI 0.85–1.18); p = 0.96). Fractional polynomial regression analyses indicated a U‐shaped dose–response relationship, with a minimum postoperative delirium risk at a cumulative ketamine dose of 0.25–0.34 mg.kg‐1.Discussion: Intra‐operative low‐dose ketamine was associated with a lower risk of postoperative delirium, while high doses did not influence the risk.